ALKEM.NS
Price:
$5089.5
Market Cap:
$608.53B
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-12-23
Stock Exchange
NSE
Ticker
ALKEM.NS
According to Alkem Laboratories Limited’s latest financial reports and current stock price. The company's current PE Ratio is 28.17. This represents a change of -22.56% compared to the average of 36.38 of the last 4 quarters.
The mean historical PE Ratio of Alkem Laboratories Limited over the last ten years is 29.38. The current 28.17 PE Ratio has changed 9.49% with respect to the historical average. Over the past ten years (40 quarters), ALKEM.NS's PE Ratio was at its highest in in the March 2023 quarter at 142.93. The PE Ratio was at its lowest in in the September 2019 quarter at 15.35.
Average
29.38
Median
27.36
Minimum
20.89
Maximum
41.26
Discovering the peaks and valleys of Alkem Laboratories Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.84%
Maximum Annual PE Ratio = 41.26
Minimum Annual Increase = -24.48%
Minimum Annual PE Ratio = 20.89
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 27.24 | 2.03% |
| 2025 | 26.70 | -19.94% |
| 2024 | 33.35 | -19.17% |
| 2023 | 41.26 | 56.84% |
| 2022 | 26.31 | 25.91% |
| 2021 | 20.89 | -15.33% |
| 2020 | 24.67 | -10.18% |
| 2019 | 27.47 | -24.48% |
| 2018 | 36.37 | 23.08% |
| 2017 | 29.55 | 35.12% |
The current PE Ratio of Alkem Laboratories Limited (ALKEM.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
29.10
5-year avg
30.97
10-year avg
29.38
Alkem Laboratories Limited’s PE Ratio is greater than Aurobindo Pharma Limited (26.25), greater than Aurobindo Pharma Limited (26.25), less than Abbott India Limited (33.62), less than Abbott India Limited (33.62), greater than Lupin Limited (17.31), less than Laurus Labs Limited (97.23), less than Laurus Labs Limited (97.23), greater than Lupin Limited (17.31), less than Glenmark Pharmaceuticals Limited (37.97), less than Glenmark Pharmaceuticals Limited (37.97),
| Company | PE Ratio | Market cap |
|---|---|---|
| 26.25 | $966.52B | |
| 26.25 | $963.65B | |
| 33.62 | $544.25B | |
| 33.62 | $542.92B | |
| 17.31 | $955.76B | |
| 97.23 | $1.06T | |
| 97.23 | $1.06T | |
| 17.31 | $957.91B | |
| 37.97 | $682.70B | |
| 37.97 | $698.14B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkem Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alkem Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alkem Laboratories Limited's PE Ratio?
How is the PE Ratio calculated for Alkem Laboratories Limited (ALKEM.NS)?
What is the highest PE Ratio for Alkem Laboratories Limited (ALKEM.NS)?
What is the 3-year average PE Ratio for Alkem Laboratories Limited (ALKEM.NS)?
What is the 5-year average PE Ratio for Alkem Laboratories Limited (ALKEM.NS)?
How does the current PE Ratio for Alkem Laboratories Limited (ALKEM.NS) compare to its historical average?